Training Program Title

Drug Development in the CER Era

Contributor

Tufts CTSI

Competency Keywords

Investigational Products; Product Development; Regulation

Public

yes

Cost to Access

no

Competency Domains

Medicines Development and Regulation

Learning Objectives

Assess the economic, regulatory, and political pressures affecting pharmaceutical and biopharmaceutical developers today Discuss current drug development metrics, including the time, cost, and risk of development Examine how companies, in response to competitive and economic pressures, are adopting new strategies and practices to improve R&D performance

Delivery Method

Online

Target Learners

Principal Investigators

Associated Assessment

no

Share

COinS